Johnson & Johnson

Thêm thông tin về Johnson & Johnson Công ty

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).

Thông tin công ty

Mã chứng khoánJNJ

Tên công tyJohnson & Johnson

Ngày IPOSep 25, 1944

Giám đốc điều hànhMr. Joaquin Boix Duato

Số lượng nhân viên138100

Loại chứng khoánOrdinary Share

Kết thúc năm tài chínhSep 25

Địa chỉOne Johnson & Johnson Plaza

Thành phốNEW BRUNSWICK

Sàn giao dịch chứng khoánNYSE Consolidated

Quốc giaUnited States of America

Mã bưu điện08933

Điện thoại17325242455

Trang webhttps://www.jnj.com/

Mã chứng khoánJNJ

Ngày IPOSep 25, 1944

Giám đốc điều hànhMr. Joaquin Boix Duato

Lãnh đạo công ty

Tên

Tên/Chức vụ

Chức vụ

Tỷ lệ sở hữu cổ phần

Thay đổi

Mr. Joaquin Boix Duato

Chairman of the Board, Chief Executive Officer

276.91K

--

Ms. Jennifer L. Taubert

Executive Vice President, Worldwide Chairman, Innovative Medicine

178.01K

--

Ms. Kathryn E. Wengel

Executive Vice President, Chief Technology Officer and Risk Officer

94.62K

+14.54%

Mr. Joseph J. Wolk

Chief Financial Officer, Executive Vice President

84.95K

--

Ms. Vanessa Broadhurst

Executive Vice President - Global Corporate Affairs

23.59K

+18.96%

Ms. Kristen Mulholland

Chief Human Resources Officer, Executive Vice President

14.12K

+20.79%

Ms. Elizabeth (Liz) Forminard

Executive Vice President, Chief Legal Officer

12.85K

+17.90%

Prof. Dr. John C. Reed, M.D., Ph.D.

Executive Vice President - Innovative Medicine, Research and Development

10.66K

-64.23%

Mr. Hubert Joly

Independent Director

5.00K

--

Ms. Marillyn A. Hewson

Lead Independent Director

3.00K

--

Xem thêm

Tên

Tên/Chức vụ

Chức vụ

Tỷ lệ sở hữu cổ phần

Thay đổi

Mr. Joaquin Boix Duato

Chairman of the Board, Chief Executive Officer

276.91K

--

Ms. Jennifer L. Taubert

Executive Vice President, Worldwide Chairman, Innovative Medicine

178.01K

--

Ms. Kathryn E. Wengel

Executive Vice President, Chief Technology Officer and Risk Officer

94.62K

+14.54%

Mr. Joseph J. Wolk

Chief Financial Officer, Executive Vice President

84.95K

--

Ms. Vanessa Broadhurst

Executive Vice President - Global Corporate Affairs

23.59K

+18.96%

Ms. Kristen Mulholland

Chief Human Resources Officer, Executive Vice President

14.12K

+20.79%

Phân tích doanh thu

Tiền tệ: USDThời gian cập nhật: CN, 6 Th07

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Theo Doanh nghiệpUSD

Tên

Doanh thu

Tỷ trọng

Oncology-DARZALEX

3.24B

14.79%

Interventional Solutions

2.10B

9.61%

Immunology-STELARA

1.63B

7.42%

Surgery-General

1.32B

6.04%

Surgery-Advanced

1.07B

4.90%

Khác

12.53B

57.24%

Theo Khu vựcUSD

Tên

Doanh thu

Tỷ trọng

United States

12.30B

56.21%

Europe

5.11B

23.34%

Asia-Pacific, Africa

3.31B

15.12%

Western Hemisphere, excluding U.S.

1.17B

5.33%

Theo Doanh nghiệp

Theo Khu vực

Theo Doanh nghiệpUSD

Tên

Doanh thu

Tỷ trọng

Oncology-DARZALEX

3.24B

14.79%

Interventional Solutions

2.10B

9.61%

Immunology-STELARA

1.63B

7.42%

Surgery-General

1.32B

6.04%

Surgery-Advanced

1.07B

4.90%

Khác

12.53B

57.24%

Thống kê Cổ phần

Thời gian cập nhật: T3, 13 Th05

Cổ đông

Loại Cổ đông

Cổ đông

Tỷ trọng

The Vanguard Group, Inc.

9.80%

State Street Global Advisors (US)

5.51%

BlackRock Institutional Trust Company, N.A.

5.39%

Geode Capital Management, L.L.C.

2.52%

JP Morgan Asset Management

1.52%

Khác

75.26%

Cổ đông

Tỷ trọng

The Vanguard Group, Inc.

9.80%

State Street Global Advisors (US)

5.51%

BlackRock Institutional Trust Company, N.A.

5.39%

Geode Capital Management, L.L.C.

2.52%

JP Morgan Asset Management

1.52%

Khác

75.26%

Loại Cổ đông

Cổ đông

Tỷ trọng

Investment Advisor

39.00%

Investment Advisor/Hedge Fund

24.11%

Research Firm

3.02%

Pension Fund

2.35%

Bank and Trust

2.18%

Insurance Company

1.62%

Sovereign Wealth Fund

1.42%

Hedge Fund

0.69%

Family Office

0.09%

Khác

25.52%

Cổ phần của tổ chức

Thời gian cập nhật: T3, 1 Th07

Chu kỳ Báo cáo

Số lượng tổ chức

Cổ phiếu nắm giữ

Tỷ trọng

Thay đổi

2025Q2

5920

1.78B

73.89%

-7.65M

2025Q1

6002

1.80B

74.62%

+4.60M

2024Q4

5953

1.78B

74.14%

+8.28M

2024Q3

5699

1.77B

73.47%

+2.69M

2024Q2

5691

1.75B

72.75%

+9.12M

2024Q1

5685

1.73B

71.58%

-6.08M

2023Q4

5686

1.72B

71.40%

-7.80M

2023Q3

5524

1.72B

71.21%

-159.24M

2023Q2

5528

1.87B

71.81%

+6.27M

2023Q1

5490

1.85B

71.21%

-28.44M

Xem thêm

Hoạt động của Cổ đông

Tên

Cổ phiếu nắm giữ

Tỷ trọng

Thay đổi

Thay đổi %

Ngày

The Vanguard Group, Inc.

232.98M

9.68%

+1.17M

+0.50%

Mar 31, 2025

State Street Global Advisors (US)

133.79M

5.56%

-666.37K

-0.50%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

129.14M

5.37%

-857.93K

-0.66%

Mar 31, 2025

Geode Capital Management, L.L.C.

59.38M

2.47%

+1.72M

+2.98%

Mar 31, 2025

JP Morgan Asset Management

35.25M

1.47%

+11.21M

+46.62%

Mar 31, 2025

State Farm Insurance Companies

34.37M

1.43%

--

Mar 31, 2025

Norges Bank Investment Management (NBIM)

30.36M

1.26%

+1.26M

+4.34%

Dec 31, 2024

Morgan Stanley Smith Barney LLC

24.07M

1%

+1.16M

+5.06%

Mar 31, 2025

Wellington Management Company, LLP

22.65M

0.94%

-1.71M

-7.02%

Mar 31, 2025

BlackRock Asset Management Ireland Limited

19.70M

0.82%

-178.45K

-0.90%

Mar 31, 2025

Xem thêm

ETF liên quan

Thời gian cập nhật: T4, 6 Th08

Tên

Tỷ trọng

iShares U.S. Pharmaceuticals ETF

23.85%

FT Vest DJIA Dogs 10 Target Income ETF

9.78%

VanEck Pharmaceutical ETF

8.38%

First Trust NASDAQ Pharmaceuticals ETF

8.12%

Health Care Select Sector SPDR Fund

7.51%

Proshares Ultra Health Care

7.51%

JPMorgan Healthcare Leaders ETF

7.42%

iShares U.S. Healthcare ETF

7.26%

iShares Core High Dividend ETF

6.49%

Fidelity MSCI Health Care Index ETF

6.48%

Xem thêm

iShares U.S. Pharmaceuticals ETF

Tỷ trọng23.85%

FT Vest DJIA Dogs 10 Target Income ETF

Tỷ trọng9.78%

VanEck Pharmaceutical ETF

Tỷ trọng8.38%

First Trust NASDAQ Pharmaceuticals ETF

Tỷ trọng8.12%

Health Care Select Sector SPDR Fund

Tỷ trọng7.51%

Proshares Ultra Health Care

Tỷ trọng7.51%

JPMorgan Healthcare Leaders ETF

Tỷ trọng7.42%

iShares U.S. Healthcare ETF

Tỷ trọng7.26%

iShares Core High Dividend ETF

Tỷ trọng6.49%

Fidelity MSCI Health Care Index ETF

Tỷ trọng6.48%

Cổ tức

Tổng cộng 56.79B USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Ngày

Cổ tức

Ngày ghi sổ

Ngày thanh toán

Ngày không hưởng cổ tức

Jan 02, 2025

JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Mar 04, 2025 going ex on Feb 18, 2025

Feb 18, 2025

Mar 04, 2025

Feb 18, 2025

Oct 15, 2024

JNJ.NB Final Cash Dividend of gross USD 1.24 paid on Dec 10, 2024 going ex on Nov 26, 2024

Nov 26, 2024

Dec 10, 2024

Nov 26, 2024

Jul 17, 2024

JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Sep 10, 2024 going ex on Aug 27, 2024

Aug 27, 2024

Sep 10, 2024

Aug 27, 2024

Apr 16, 2024

JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Jun 04, 2024 going ex on May 20, 2024

May 21, 2024

Jun 04, 2024

May 20, 2024

Jan 02, 2024

JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Mar 05, 2024 going ex on Feb 16, 2024

Feb 20, 2024

Mar 05, 2024

Feb 16, 2024

Oct 19, 2023

JNJ.NB Final Cash Dividend of gross USD 1.19 paid on Dec 05, 2023 going ex on Nov 20, 2023

Nov 21, 2023

Dec 05, 2023

Nov 20, 2023

Jul 20, 2023

JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Sep 07, 2023 going ex on Aug 25, 2023

Aug 28, 2023

Sep 07, 2023

Aug 25, 2023

Apr 18, 2023

JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Jun 06, 2023 going ex on May 22, 2023

May 23, 2023

Jun 06, 2023

May 22, 2023

Jan 03, 2023

JNJ.NB Interim Cash Dividend of gross USD 1.13 paid on Mar 07, 2023 going ex on Feb 17, 2023

Feb 21, 2023

Mar 07, 2023

Feb 17, 2023

Oct 18, 2022

JNJ.NB Final Cash Dividend of gross USD 1.13 paid on Dec 06, 2022 going ex on Nov 21, 2022

Nov 22, 2022

Dec 06, 2022

Nov 21, 2022

Xem thêm

Chia tách cổ phiếu

Ngày

Loại

Tỷ lệ

Không có dữ liệu

Ngày

Loại

Tỷ lệ

Không có dữ liệu

177.180USD

Johnson & Johnson

177.180

Tổng quan

Công ty

Tài chính

Phân tích